Patients with haematological cancers will be the next priority for COVID-19 vaccine when phase 1b of the rollout commences on 22 March. With phase 1a having targeted frontline COVID-19 workers to receive Pfizer’s vaccine (‘Comirnaty’) through clinic hubs, the next phase, 1b, is planned to deliver up to 15 million doses of the Oxford/AstraZeneca vaccine ...
Haematology patients eligible for COVID-19 vaccine from 22 March: but which one?
By Michael Woodhead
8 Mar 2021